Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Harron

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
British Journal of Clinical Pharmacology|May 1, 1985
Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in manJ M Arnold, P C O'Connor, J G Riddell, et al.
British Journal of Clinical Pharmacology|December 1, 1985
Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteersP C O'Connor, M J Finch, D W Harron, et al.
Family Practice|February 1, 1996
Doing randomized controlled trials in a developing country: some practical realitiesN J Glasgow, J C Murdoch, L Baynouna, et al.
British Journal of Clinical Pharmacology|February 1, 1981
Observation on the efficacy and pharmacokinetics of betaxolol (SL 75212), a cardioselective beta-adrenoceptor blocking drugK Balnave, J D Neill, C J Russell, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|May 1, 1990
Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasisM E Mandour, H el Turabi, M M Homeida, et al.
British Journal of Clinical Pharmacology|March 1, 1985
Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonistP C O'Connor, J M Arnold, A N Brown, et al.
Cardiovascular Research|July 1, 1988
The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusionM J Walker, M J Curtis, D J Hearse, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
British Journal of Clinical Pharmacology|May 1, 1985
Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in manJ M Arnold, P C O'Connor, J G Riddell, et al.
British Journal of Clinical Pharmacology|December 1, 1985
Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteersP C O'Connor, M J Finch, D W Harron, et al.
Family Practice|February 1, 1996
Doing randomized controlled trials in a developing country: some practical realitiesN J Glasgow, J C Murdoch, L Baynouna, et al.
British Journal of Clinical Pharmacology|February 1, 1981
Observation on the efficacy and pharmacokinetics of betaxolol (SL 75212), a cardioselective beta-adrenoceptor blocking drugK Balnave, J D Neill, C J Russell, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|May 1, 1990
Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasisM E Mandour, H el Turabi, M M Homeida, et al.
British Journal of Clinical Pharmacology|March 1, 1985
Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonistP C O'Connor, J M Arnold, A N Brown, et al.
Cardiovascular Research|July 1, 1988
The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusionM J Walker, M J Curtis, D J Hearse, et al.
Pageof 9